Literature DB >> 6196821

The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis.

G Balldin, A Borgström, S Genell, K Ohlsson.   

Abstract

Fifty-five patients with severe acute pancreatitis were treated with peritoneal lavage at the Dept. of Surgery at Malmö General Hospital. In a randomized study 26 of the 55 patients received in addition 500,000 KIU aprotinin in the lavage fluid every 2 h. There were no significant differences between the aprotinin- and non-aprotinin-treated groups as to mortality and clinical results. The initial concentration of alpha 1-antitrypsin in plasma was mainly within normal range with increasing values during the treatment. No differences were seen between the two groups. The initial mean level of alpha 2-macroglobulin in plasma was slightly decreased, but 17 patients showed values below normal range. The alpha 2-macroglobulin level during the lavage showed a similar course in the two groups. alpha 1-Antitrypsin and alpha 2-macroglobulin in the lavage fluids showed signs of complexation but in plasma these inhibitors did not show any signs of complexation. On admission to the hospital the mean levels of C3 and kininogen in the plasma were slightly below normal. During the lavage treatment no differences were seen between the two groups. Degradation products of C3 and kininogen were seen in both serum and peritoneal fluids. The electrophoretic patterns of C3 and kininogen normalized in serum as well as in lavage fluids during the lavage treatment without any significant differences in the two groups. High levels of immunoreactive trypsin, pancreatic elastase, PSTI, and leukocyte elastase in serum were seen equally in both groups of patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196821     DOI: 10.1007/bf01855643

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  12 in total

1.  Peritoneal lavage for severe acute pancreatitis: a systematic review of randomised trials.

Authors:  Zhiyong Dong; Maxim S Petrov; Jing Xu; Satyanarayan Shanbhag; John A Windsor; Shijiang Pang
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  High-dose intraperitoneal aprotinin treatment of acute severe pancreatitis: a double-blind randomized multi-center trial.

Authors:  R Berling; S Genell; K Ohlsson
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

3.  Ulinastatin enhances the therapeutic effect of intraperitoneal lavage on severe acute pancreatitis in rats.

Authors:  Cong Feng; Xuan Su; L I Chen; Xuan Zhou; Bei Li; Li-Li Wang; Fa-Qin Lv; Tan-Shi Li
Journal:  Exp Ther Med       Date:  2015-03-09       Impact factor: 2.447

4.  Drug Therapy for Acute Pancreatitis.

Authors:  Yan Bi; Tegpal Atwal; Santhi Swaroop Vege
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

Review 5.  Pharmacological interventions for acute pancreatitis.

Authors:  Elisabetta Moggia; Rahul Koti; Ajay P Belgaumkar; Federico Fazio; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

Review 6.  Pharmacologic therapy for acute pancreatitis.

Authors:  Swetha Kambhampati; Walter Park; Aida Habtezion
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

7.  Long peritoneal lavage decreases pancreatic sepsis in acute pancreatitis.

Authors:  J H Ranson; R S Berman
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

8.  Effective peritoneal therapy of acute pancreatitis in the rat with glutaryl-trialanin-ethylamide: a novel inhibitor of pancreatic elastase.

Authors:  P Fric; J Slabý; E Kasafírek; P Kocna; J Marek
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

9.  Clinical trial with a protease inhibitor gabexate mesilate in acute pancreatitis.

Authors:  H Harada; H Miyake; K Ochi; J Tanaka; I Kimura
Journal:  Int J Pancreatol       Date:  1991

10.  Clinical pancreatology I: Pancreatic medical history.

Authors:  Ake Andrén-Sandberg
Journal:  N Am J Med Sci       Date:  2010-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.